EWM
MDCO

Evercore Wealth Management’s Medicines Co MDCO Stock Holding History

Evercore Wealth Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-828
Closed -$31K – 1035
2015
Q4 		$31K Buy
+828
New +$31.3K ﹤0.01% 685

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Evercore Wealth Management's MDCO Position: Q1 2016 in Review

Evercore Wealth Management sold out of Medicines Co (MDCO) in Q1 2016, closing a stake of 828 shares — an estimated $31K sold.

Evercore Wealth Management first reported a position in MDCO in Q4 2015 and held it in 1 quarter. The position peaked at $31K in Q4 2015. 181 funds tracked by Wall St. Rank hold MDCO as of Q1 2016.

  • Evercore Wealth Management reported no remaining Medicines Co position as of Q1 2016 after selling out during the quarter.
  • Evercore Wealth Management sold 828 Medicines Co shares in Q1 2016, an estimated $31K.
  • Evercore Wealth Management first reported a position in Medicines Co in Q4 2015 and held it in 1 quarter.
  • Evercore Wealth Management's Medicines Co position peaked at $31K in Q4 2015.
  • 181 funds tracked by Wall St. Rank held Medicines Co as of Q1 2016.

Based on Evercore Wealth Management's 13F filing for Q1 2016, filed 2 May 2016.